(Q36127397)

12 August 2017

1 reference

title

New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development (English)

1 reference

World Health Organization

12 August 2017

1 reference

13

object named as

World Health Organization

0 references

author name string

Arun T Kamath

1

1 reference

12 August 2017

Uli Fruth

2

1 reference

12 August 2017

Michael J Brennan

3

1 reference

12 August 2017

Roland Dobbelaer

4

1 reference

12 August 2017

Peter Hubrechts

5

1 reference

12 August 2017

Mei Mei Ho

6

1 reference

12 August 2017

Ronald E Mayner

7

1 reference

12 August 2017

Jelle Thole

8

1 reference

12 August 2017

K Barry Walker

9

1 reference

12 August 2017

Margaret Liu

10

1 reference

12 August 2017

Paul-Henri Lambert

11

1 reference

12 August 2017

AERAS Global TB Vaccine Foundation

12

1 reference

12 August 2017

language of work or name

English

0 references

publication date

24 March 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

23

1 reference

12 August 2017

issue

29

1 reference

12 August 2017

page(s)

3753-3761

1 reference

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

How can immunology contribute to the control of tuberculosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

A novel TB vaccine; towards a strategy based on our understanding of BCG failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

Comparative genomics of BCG vaccines by whole-genome DNA microarray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

IS6110 mediates increased transcription of the phoP virulence gene in a multidrug-resistant clinical isolate responsible for tuberculosis outbreaks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

Neonatal and early life vaccinology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

An essential role for phoP in Mycobacterium tuberculosis virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.001

10.1016/J.VACCINE.2005.03.001

7 January 2021

Identifiers

DOI

1 reference

12 August 2017

1 reference